[1] |
Hunter KD, Parkinson EK, Harrison PR . Profiling early head and neck cancer[J]. Nat Rev Cancer, 2005,5(2):127-135.
doi: 10.1038/nrc1549
URL
pmid: 15685196
|
[2] |
Forastiere A, Koch W, Trotti A , et al. Head and neck cancer[J]. N Engl J Med, 2001,26(345):1890-1900.
|
[3] |
Dienstmann R, Rodon J, Prat A , et al. Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors[J]. Ann Oncol, 2014,25(3):552-563.
doi: 10.1093/annonc/mdt419
URL
pmid: 24265351
|
[4] |
Beenken A, Mohammadi M . The FGF family: biology, pathophysiology and therapy[J]. Nat Rev Drug Discov, 2009,8(3):235-253.
doi: 10.1038/nrd2792
URL
pmid: 19247306
|
[5] |
Trueb B . Biology of FGFRL1, the fifth fibroblast growth factor receptor[J]. Cell Mol Life Sci, 2011,68(6):951-964.
doi: 10.1007/s00018-010-0576-3
URL
|
[6] |
Sleeman M, Fraser J, McDonald M, et al. Identification of a new fibroblast growth factor receptor, FGFR5[J]. Gene, 2001,271(2):171-182.
doi: 10.1016/s0378-1119(01)00518-2
URL
pmid: 11418238
|
[7] |
Trueb B, Neuhauss SC, Baertschi S , et al. Fish possess multiple copies of fgfrl1, the gene for a novel FGF receptor[J]. Biochim Biophys Acta, 2005,1727(1):65-74.
doi: 10.1016/j.bbaexp.2004.12.001
URL
pmid: 15652159
|
[8] |
Ibrahimi OA, Yeh BK, Eliseenkova AV , et al. Analysis of mutations in fibroblast growth factor(FGF) and a pathogenic mutation in FGF receptor(FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization[J]. Mol Cell Biol, 2005,25(2):671-684.
doi: 10.1128/MCB.25.2.671-684.2005
URL
pmid: 15632068
|
[9] |
Stauber DJ , DiGabriele AD, Hendrickson WA. Structural interactions of fibroblast growth factor receptor with its ligands[J]. Proc Natl Acad Sci U S A, 2000,97(1):49-54.
doi: 10.1073/pnas.97.1.49
URL
pmid: 10618369
|
[10] |
Zuo J, Wen M, Lei M , et al. MiR-210 links hypoxia with cell proliferation regulation in human Laryngocarcinoma cancer[J]. J Cell Biochem, 2015,116(6):1039-1049.
doi: 10.1002/jcb.25059
URL
pmid: 25639884
|
[11] |
Tsuchiya S . The role of microRNA-210 in esophageal squamous cell carcinoma[J]. Yakugaku Zasshi, 2012,132(9):1069-1073.
|
[12] |
Takei Y, Matsumura T, Watanabe K , et al. FGFRL1 deficiency reduces motility and tumorigenic potential of cells derived from oesophageal squamous cell carcinomas[J]. Oncol Lett, 2018,16(1):809-814.
doi: 10.3892/ol.2018.8739
URL
pmid: 29963148
|
[13] |
Schild C, Trueb B . Aberrant expression of FGFRL1, a novel FGF receptor, in ovarian tumors[J]. Int J Mol Med, 2005,16(6):1169-1173.
URL
pmid: 16273302
|
[14] |
Gerber SD, Steinber F, Beyeler M , et al. The murine Fgfrl1 receptor is essential for the development of the metanephric kidney[J]. Dev Biol, 2009,335(1):106-119.
doi: 10.1016/j.ydbio.2009.08.019
URL
pmid: 19715689
|
[15] |
Steinber F, Gerber SD, Rieckmann T , et al. Rapid fusion and syncytium formation of heterologous cell upon expression of the FGFRL1 receptor[J]. J Biol Chem, 2010,285(48):37704-37715.
doi: 10.1074/jbc.M110.140517
URL
pmid: 20851884
|
[16] |
Kim I, Moon S, Yu K , et al. A novel fibroblast growth factor receptor 5 preferentially expressed in the pancreas[J]. Biochim Biophys Acta, 2001,1518(1/2):152-156.
|
[17] |
Trueb B, Taeschler S . Expression of FGFRL1, a novel fibroblast growth factor receptor, during embryonic development[J]. Int J Mol Med, 2006,17(4):617-620.
URL
pmid: 16525717
|
[18] |
Chen R, Li D, Zheng M , et al. FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1[J]. J Cell Mol Med, 2020,24(3):2123-2134.
doi: 10.1111/jcmm.14763
URL
pmid: 31957179
|
[19] |
Tsuchiya S, Fujiwara T, Sato F , et al. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1)[J]. J Biol Chem, 2011,286(1):420-428.
doi: 10.1074/jbc.M110.170852
URL
pmid: 21044961
|
[20] |
Trueb B, Zhuang L, Taeschler S , et al. Characterization of FGFRL1, a novel fibroblast growth factor (FGF) receptor preferentially expressed in skeletal tissues[J]. J Biol Chem, 2003,278(36):33857-33865.
doi: 10.1074/jbc.M300281200
URL
pmid: 12813049
|
[21] |
Zhuang L, Steinberg F, Trueb B . Receptor FGFRL1 acts as a tumor suppressor in nude mice when overexpressed in HEK 293 Tet-On cells[J]. Oncol Lett, 2016,12(6):4524-4530.
doi: 10.3892/ol.2016.5245
URL
pmid: 28101211
|
[22] |
Shimada Y, Okumura T, Nagata T , et al. Expression esophageal squamous cell carcinoma[J]. Esophagus, 2014,11:48-53.
doi: 10.1007/s10388-013-0394-4
URL
|
[23] |
Xu Q, Sun Q, Zhang J , et al. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer[J]. Carcinogenesis, 2013,34(3):539-549.
doi: 10.1093/carcin/bgs374
URL
|
[24] |
Li J, Zhou BP . Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters[J]. BMC Cancer, 2011,11:49.
doi: 10.1186/1471-2407-11-49
URL
pmid: 21284870
|
[25] |
Mendelsohn AH, Lai CK, Shintaku IP , et al. Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma[J]. Am J Otolaryngol, 2012,33(1):6-13.
doi: 10.1016/j.amjoto.2010.11.018
URL
pmid: 21439681
|
[26] |
Liu CY, Lin HH, Tang MJ , et al. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation[J]. Oncotarget, 2015,6(18):15966-15983.
doi: 10.18632/oncotarget.3862
URL
pmid: 25965826
|
[27] |
Berx G, Raspe E, Christofori G , et al. Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer[J]. Clin Exp Metastasis, 2007,24(8):587-597.
doi: 10.1007/s10585-007-9114-6
URL
pmid: 17978854
|
[28] |
Thiery JP, Acloque H, Huang RY , et al. Epithelial-mesenchymal transitions in development and disease[J]. Cell, 2009,139(5):871-890.
doi: 10.1016/j.cell.2009.11.007
URL
pmid: 19945376
|
[29] |
Lamouille S, Xu J, Derynck R . Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014,15(3):178-196.
doi: 10.1038/nrm3758
URL
pmid: 24556840
|